3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Breast Neoplasms
4
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Seminoma
1
Prostate Cancer Metastatic
1
Ovarian Neoplasms
1
Neutropenia
1
Neoplasms
1
Lymphoma, B-Cell
1
Hodgkin Disease
1
Endodermal Sinus Tumor
1
Central Nervous System Neoplasms
1
Castrate Resistant Prostate Cancer
1
Interventions
Paclitaxel
7
Ifosfamide
7
Cisplatin
5
Filgrastim
4
Etoposide
4
Carboplatin
3
pegfilgrastim
2
Therapeutics
2
Granulocyte Colony-Stimulating Factor
2
Drug Therapy
2
liposomal amphotericin B
1
etoposide phosphate
1
Vinblastine
1
Thiotepa
1
Sunitinib
1
Ribavirin
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Peripheral Blood Stem Cell Transplantation
1
Palivizumab
1
Oxaliplatin
1
Nivolumab
1
Mesna
1
Lenograstim
1
Itraconazole
1
Interleukin-12 Subunit p35
1
Interleukin-11
1
Gemcitabine
1
Fluconazole
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endodermal Sinus Tumor
×
Lenograstim
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled